<html xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Erythropoietin.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:06:52 GMT -->
<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 11">
<meta name=Originator content="Microsoft Word 11">
<link rel=File-List href="javascript:if(confirm('http://www.vietstarse.com/duocthu/Documents/Erythropoietin_files/filelist.xml  \n\nThis file was not retrieved by Teleport Pro, because the server reports that this file cannot be found.  \n\nDo you want to open it from the server?'))window.location='http://www.vietstarse.com/duocthu/Documents/Erythropoietin_files/filelist.xml'" tppabs="http://www.vietstarse.com/duocthu/Documents/Erythropoietin_files/filelist.xml">
<title>ERYTHROPOIETIN</title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>VIETSTAR</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>lylv</o:LastAuthor>
  <o:Revision>3</o:Revision>
  <o:TotalTime>0</o:TotalTime>
  <o:Created>2006-08-09T04:46:00Z</o:Created>
  <o:LastSaved>2006-08-09T04:46:00Z</o:LastSaved>
  <o:Pages>4</o:Pages>
  <o:Words>1766</o:Words>
  <o:Characters>10070</o:Characters>
  <o:Company>VS</o:Company>
  <o:Lines>83</o:Lines>
  <o:Paragraphs>23</o:Paragraphs>
  <o:CharactersWithSpaces>11813</o:CharactersWithSpaces>
  <o:Version>11.5606</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:DoNotHyphenateCaps/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas>false</w:ValidateAgainstSchemas>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotUnderlineInvalidXML/>
  <w:Compatibility>
   <w:SelectEntireFieldWithStartOrEnd/>
   <w:UseWord2002TableStyleRules/>
  </w:Compatibility>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
 </w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" LatentStyleCount="156">
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:536871559 0 0 0 415 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-alt:Arial;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1627421319 -2147483648 8 0 66047 0;}
@font-face
	{font-family:TahomaH;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-alt:Arial;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-font-kerning:0pt;}
h2
	{mso-style-next:Normal;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:9.0pt;
	font-family:Tahoma;}
h3
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	layout-grid-mode:char;
	font-size:14.0pt;
	font-family:Tahoma;
	font-weight:normal;
	font-style:italic;}
h4
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:4;
	font-size:9.0pt;
	font-family:Tahoma;
	font-weight:normal;}
h5
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:5;
	font-size:9.0pt;
	font-family:Tahoma;}
h6
	{mso-style-next:Normal;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.3pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:6;
	font-size:9.0pt;
	font-family:Tahoma;
	font-style:italic;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:7;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:8;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:9;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoFootnoteText, li.MsoFootnoteText, div.MsoFootnoteText
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:right 411.1pt;
	border:none;
	mso-border-bottom-alt:solid windowtext .5pt;
	padding:0in;
	mso-padding-alt:0in 0in 1.0pt 0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:center 3.0in right 6.0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoCaption, li.MsoCaption, div.MsoCaption
	{mso-style-noshow:yes;
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
span.MsoFootnoteReference
	{mso-style-noshow:yes;
	vertical-align:super;}
span.MsoCommentReference
	{mso-style-noshow:yes;
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;}
span.MsoPageNumber
	{mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:Tahoma;
	mso-ascii-font-family:Tahoma;
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:TahomaH;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:TahomaH;
	font-weight:bold;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-2.0in;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:14.2pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.7pt;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-14.15pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	mso-layout-grid-align:none;
	punctuation-wrap:simple;
	text-autospace:none;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	background:navy;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.1, li.1, div.1
	{mso-style-name:1;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.1nho, li.1nho, div.1nho
	{mso-style-name:1nho;
	margin-top:3.5pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.2, li.2, div.2
	{mso-style-name:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.3, li.3, div.3
	{mso-style-name:3;
	mso-style-parent:2;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.5, li.5, div.5
	{mso-style-name:5;
	mso-style-parent:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.bai, li.bai, div.bai
	{mso-style-name:bai;
	mso-style-parent:"Heading 2";
	margin-top:25.0pt;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.4pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.BodyText21, li.BodyText21, div.BodyText21
	{mso-style-name:"Body Text 21";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.cach0, li.cach0, div.cach0
	{mso-style-name:"cach0\,4";
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.chucach, li.chucach, div.chucach
	{mso-style-name:chucach;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.normal1, li.normal1, div.normal1
	{mso-style-name:normal1;
	mso-style-parent:"cach0\,4";
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	mso-style-parent:"Heading 2";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:48.2pt;
	text-align:justify;
	text-indent:-17.0pt;
	line-height:150%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	tab-stops:list 49.2pt;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:8.5in 11.0in;
	margin:1.0in 1.25in 1.0in 1.25in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman";
	mso-ansi-language:#0400;
	mso-fareast-language:#0400;
	mso-bidi-language:#0400;}
</style>
<![endif]-->
</head>

<body lang=EN-US style='tab-interval:.5in'>

<div class=Section1>

<h1 align=center style='text-align:center;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:15.0pt;line-height:150%;font-family:
Verdana'>ERYTHROPOIETIN<o:p></o:p></span></h1>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><b><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tên chung qu&#7889;c t&#7871;</span></b><span style='font-size:9.0pt;
mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>:
Erythropoietin.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><b><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Mã ATC:</span></b><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'> B03X A01.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><b><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Lo&#7841;i thu&#7889;c:</span></b><span style='font-size:9.0pt;
mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'> Thu&#7889;c
kích thích t&#7841;o h&#7891;ng c&#7847;u.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>D&#7841;ng thu&#7889;c và hàm
l&#432;&#7907;ng<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Thu&#7889;c n&#432;&#7899;c &#273;&#7875; tiêm 2000 &#273;vqt/ml; 4000
&#273;vqt/ml; 5000 &#273;vqt/ml; 10000 &#273;vqt/ml.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>D&#432;&#7907;c lý và c&#417; ch&#7871;
tác d&#7909;ng<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Erythropoietin là m&#7897;t hormon thi&#7871;t y&#7871;u &#273;&#7875;
t&#7841;o h&#7891;ng c&#7847;u t&#7915; mô dòng h&#7891;ng c&#7847;u trong t&#7911;y
x&#432;&#417;ng. Ph&#7847;n l&#7899;n hormon này do th&#7853;n s&#7843;n xu&#7845;t
&#273;&#7875; &#273;áp &#7913;ng v&#7899;i thi&#7871;u oxygen mô, m&#7897;t ph&#7847;n
nh&#7887; (10% &#273;&#7871;n 14%) do gan t&#7893;ng h&#7907;p (gan là c&#417;
quan chính s&#7843;n xu&#7845;t ra erythropoietin &#7903; bào thai).
Erythropoietin tác d&#7909;ng nh&#432; m&#7897;t y&#7871;u t&#7889; t&#259;ng
tr&#432;&#7903;ng, kích thích ho&#7841;t tính gián phân các t&#7871; bào g&#7889;c
dòng h&#7891;ng c&#7847;u và các t&#7871; bào ti&#7873;n thân s&#7899;m h&#7891;ng
c&#7847;u (ti&#7873;n nguyên h&#7891;ng c&#7847;u). Hormon này c&#361;ng còn có
tác d&#7909;ng gây bi&#7879;t hóa, kích thích bi&#7871;n &#273;&#7893;i
&#273;&#417;n v&#7883; t&#7841;o qu&#7847;n th&#7875; h&#7891;ng c&#7847;u
(CFU) thành ti&#7873;n nguyên h&#7891;ng c&#7847;u.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Epoetin alpha và epoetin beta là nh&#7919;ng erythropoietin ng&#432;&#7901;i
tái t&#7893; h&#7907;p, ch&#7913;a 165 acid amin. Epoetin và erythropoietin t&#7921;
nhiên hoàn toàn gi&#7889;ng nhau v&#7873; trình t&#7921; acid amin và có chu&#7895;i
oligosaccharid r&#7845;t gi&#7889;ng nhau trong c&#7845;u trúc hydrat carbon.
Phân t&#7917; c&#7911;a chúng có nhi&#7873;u nhóm glycosyl nh&#432;ng epoetin
alpha và epoetin beta khác nhau v&#7873; v&#7883; trí các nhóm glycosyl.
Epoetin có tác d&#7909;ng sinh h&#7885;c nh&#432; erythropoietin n&#7897;i sinh
và ho&#7841;t tính là 129000 &#273;&#417;n v&#7883; cho 1 mg hormon.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Sau khi tiêm kho&#7843;ng 1 tu&#7847;n, epoetin làm t&#259;ng
&#273;áng k&#7875; t&#7871; bào g&#7889;c t&#7841;o máu &#7903; ngo&#7841;i vi.
Trong vòng 3 &#273;&#7871;n 4 tu&#7847;n, hematocrit t&#259;ng, ph&#7909; thu&#7897;c
vào li&#7873;u dùng. Các t&#7871; bào g&#7889;c (CFU - GM và CFU - mix) bình
th&#432;&#7901;ng không ph&#7843;i là nh&#7919;ng t&#7871; bào s&#7843;n xu&#7845;t
h&#7891;ng c&#7847;u. Nh&#432; v&#7853;y, khi &#273;&#432;&#7907;c dùng v&#7899;i
li&#7873;u &#273;i&#7873;u tr&#7883;, epoetin có th&#7875; tác d&#7909;ng lên c&#7843;
hai dòng t&#7871; bào (dòng h&#7891;ng c&#7847;u và dòng t&#7911;y bào).<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>&#7903; ng&#432;&#7901;i b&#7879;nh thi&#7871;u máu do thi&#7871;u s&#7855;t
ho&#7863;c do m&#7845;t máu kín &#273;áo, erythropoietin có th&#7875; không gây
&#273;&#432;&#7907;c &#273;áp &#7913;ng ho&#7863;c duy trì tác d&#7909;ng.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Erythropoietin không tác d&#7909;ng khi u&#7889;ng. D&#432;&#7907;c
&#273;&#7897;ng h&#7885;c c&#7911;a erythropoietin tiêm d&#432;&#7899;i da khác
v&#7899;i khi tiêm t&#297;nh m&#7841;ch và &#273;&#432;&#7901;ng d&#432;&#7899;i
da có &#432;u &#273;i&#7875;m h&#417;n vì cho phép duy trì v&#7899;i li&#7873;u
th&#7845;p h&#417;n. Sau khi tiêm d&#432;&#7899;i da 12 - 18 gi&#7901;, n&#7891;ng
&#273;&#7897; trong huy&#7871;t thanh &#273;&#7841;t m&#7913;c cao nh&#7845;t.
N&#7917;a &#273;&#7901;i c&#7911;a thu&#7889;c sau khi tiêm t&#297;nh m&#7841;ch
là kho&#7843;ng 5 gi&#7901;; còn sau khi tiêm d&#432;&#7899;i da là trên 20 gi&#7901;
và n&#7891;ng &#273;&#7897; thu&#7889;c trong huy&#7871;t thanh v&#7851;n gi&#7919;
&#7903; m&#7913;c cao cho &#273;&#7871;n gi&#7901; th&#7913; 48. Do &#273;ó,
cách dùng thu&#7889;c kinh &#273;i&#7875;n hi&#7879;n nay cho ph&#7847;n l&#7899;n
các ch&#7881; &#273;&#7883;nh là m&#7897;t tu&#7847;n 3 l&#7847;n. Thu&#7889;c
chuy&#7875;n hóa &#7903; m&#7897;t m&#7913;c &#273;&#7897; nh&#7845;t &#273;&#7883;nh
và m&#7897;t l&#432;&#7907;ng nh&#7887; thu&#7889;c tìm th&#7845;y trong
n&#432;&#7899;c ti&#7875;u.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Ch&#7881; &#273;&#7883;nh<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Thi&#7871;u máu &#7903; ng&#432;&#7901;i suy th&#7853;n, k&#7875; c&#7843;
&#7903; ng&#432;&#7901;i b&#7879;nh ph&#7843;i hay không ph&#7843;i ch&#7841;y
th&#7853;n nhân t&#7841;o.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Thi&#7871;u máu do các nguyên nhân khác nh&#432; b&#7883; AIDS, viêm
kh&#7899;p d&#7841;ng th&#7845;p.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tr&#7867; &#273;&#7867; non thi&#7871;u máu và thi&#7871;u máu do hóa
tr&#7883; li&#7879;u ung th&#432; gây ra.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ð&#7875; gi&#7843;m b&#7899;t truy&#7873;n máu &#7903; ng&#432;&#7901;i
b&#7879;nh b&#7883; ph&#7851;u thu&#7853;t.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Ch&#7889;ng ch&#7881; &#273;&#7883;nh
<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>T&#259;ng huy&#7871;t áp không ki&#7875;m soát &#273;&#432;&#7907;c.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Quá m&#7851;n v&#7899;i albumin ho&#7863;c s&#7843;n ph&#7849;m t&#7915;
t&#7871; bào &#273;&#7897;ng v&#7853;t có vú.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Th&#7853;n tr&#7885;ng<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ng&#432;&#7901;i b&#7879;nh thi&#7871;u máu c&#7909;c b&#7897; c&#417;
tim.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ng&#432;&#7901;i b&#7879;nh t&#259;ng tr&#432;&#417;ng l&#7921;c
c&#417; mà không ki&#7875;m soát &#273;&#432;&#7907;c chu&#7897;t rút, có ti&#7873;n
s&#7917; &#273;&#7897;ng kinh,<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ng&#432;&#7901;i b&#7879;nh t&#259;ng ti&#7875;u c&#7847;u.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Có b&#7879;nh v&#7873; máu k&#7875; c&#7843; thi&#7871;u máu h&#7891;ng
c&#7847;u li&#7873;m, các h&#7897;i ch&#7913;ng lo&#7841;n s&#7843;n t&#7911;y,
tình tr&#7841;ng máu d&#7877; &#273;ông.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Dùng erythropoietin cho các v&#7853;n &#273;&#7897;ng viên b&#7883;
coi là dùng ch&#7845;t kích thích. Thi&#7871;u giám sát c&#7911;a th&#7847;y
thu&#7889;c và không theo dõi tình tr&#7841;ng m&#7845;t n&#432;&#7899;c trong
khi thi &#273;&#7845;u &#273;òi h&#7887;i dai s&#7913;c thì d&#7877; x&#7843;y
ra các h&#7853;u qu&#7843; nghiêm tr&#7885;ng v&#7873; s&#7921; thay &#273;&#7893;i
&#273;&#7897; quánh c&#7911;a máu, có th&#7875; gây t&#7917; vong.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tác d&#7909;ng c&#7911;a erythropoietin b&#7883; ch&#7853;m ho&#7863;c
gi&#7843;m do nhi&#7873;u nguyên nhân nh&#432;: thi&#7871;u s&#7855;t, nhi&#7877;m
khu&#7849;n, viêm hay ung th&#432;, b&#7879;nh v&#7873; máu (thi&#7871;u máu
thalassemi, thi&#7871;u máu kháng tr&#7883; li&#7879;u, t&#7911;y
x&#432;&#417;ng lo&#7841;n s&#7843;n), thi&#7871;u acid folic ho&#7863;c thi&#7871;u
vitamin B<sub>12</sub>, tan máu, nhi&#7877;m &#273;&#7897;c nhôm.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Th&#7901;i k&#7923; mang thai<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Hình nh&#432; erythropoietin n&#7897;i sinh không qua nhau thai &#273;&#7875;
t&#7899;i thai. Không có b&#7857;ng ch&#7913;ng nào cho th&#7845;y
erythropoietin ng&#432;&#7901;i tái t&#7893; h&#7907;p có qua nhau thai và vào
thai. Dùng erythropoietin nhân t&#7841;o &#273;ó không gây nguy hi&#7875;m gì
cho thai nhi. Vì thi&#7871;u máu và c&#7847;n thi&#7871;t truy&#7873;n máu nhi&#7873;u
l&#7847;n c&#361;ng gây nguy c&#417; &#273;áng k&#7875; cho m&#7865; và thai
nhi, nên l&#7907;i ích dùng erythropoietin v&#7851;n tr&#7897;i h&#417;n nguy
c&#417; &#273;&#432;&#7907;c bi&#7871;t.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Th&#7901;i k&#7923; cho con bú<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Erythropoietin không bài ti&#7871;t vào s&#7919;a. Không có nguy
c&#417; u&#7889;ng ph&#7843;i thu&#7889;c này qua &#273;&#432;&#7901;ng s&#7919;a
&#273;&#7889;i v&#7899;i tr&#7867; &#273;ang bú m&#7865;.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Tác d&#7909;ng không mong mu&#7889;n
(ADR)<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tác d&#7909;ng không mong mu&#7889;n t&#432;&#417;ng &#273;&#7889;i nh&#7865;
và th&#432;&#7901;ng ph&#7909; thu&#7897;c vào li&#7873;u. Tiêm t&#297;nh m&#7841;ch
hay gây ra tác d&#7909;ng ph&#7909; h&#417;n tiêm d&#432;&#7899;i da.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Th&#432;&#7901;ng g&#7863;p, ADR &gt; 1/100<o:p></o:p></span></i></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Toàn thân: Nh&#7913;c &#273;&#7847;u, phù, &#7899;n l&#7841;nh và
&#273;au x&#432;&#417;ng (tri&#7879;u ch&#7913;ng gi&#7889;ng c&#7843;m cúm) ch&#7911;
y&#7871;u &#7903; vào m&#361;i tiêm t&#297;nh m&#7841;ch &#273;&#7847;u tiên.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tu&#7847;n hoàn: T&#259;ng huy&#7871;t áp, huy&#7871;t kh&#7889;i
n&#417;i tiêm t&#297;nh m&#7841;ch, c&#7909;c &#273;ông máu trong máy th&#7849;m
tích, ti&#7875;u c&#7847;u t&#259;ng nh&#7845;t th&#7901;i.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Máu: Thay &#273;&#7893;i quá nhanh v&#7873; hematocrit, t&#259;ng kali
huy&#7871;t.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt'>Th&#7847;n kinh: Chu&#7897;t rút, c&#417;n &#273;&#7897;ng
kinh toàn th&#7875;.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Da: Kích &#7913;ng t&#7841;i ch&#7895;, tr&#7913;ng cá, &#273;au &#7903;
ch&#7895; tiêm d&#432;&#7899;i da.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Hi&#7871;m g&#7863;p, ADR &lt;1/1000<o:p></o:p></span></i></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tu&#7847;n hoàn: T&#259;ng ti&#7875;u c&#7847;u, c&#417;n &#273;au th&#7855;t
ng&#7921;c.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Vã m&#7891; hôi.<span style='mso-tab-count:1'>        </span><o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>H&#432;&#7899;ng d&#7851;n cách x&#7917;
trí ADR<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>C&#7847;n theo dõi hematocrit m&#7897;t cách th&#432;&#7901;ng xuyên
và &#273;i&#7873;u ch&#7881;nh li&#7873;u theo &#273;áp &#7913;ng n&#7891;ng
&#273;&#7897; hemoglobin.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ð&#7875; tránh t&#259;ng &#273;ông máu gây t&#7855;c m&#7841;ch, sau
khi &#273;ã tiêm thu&#7889;c vào t&#297;nh m&#7841;ch thì tiêm thêm ngay 10 ml
dung d&#7883;ch mu&#7889;i &#273;&#7859;ng tr&#432;&#417;ng và t&#259;ng li&#7873;u
heparin trong khi ch&#7841;y th&#7853;n nhân t&#7841;o &#273;&#7875; phòng huy&#7871;t
kh&#7889;i.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Khi t&#259;ng huy&#7871;t áp t&#7899;i m&#7913;c nguy hi&#7875;m mà
các li&#7879;u pháp ch&#7889;ng t&#259;ng huy&#7871;t áp không có k&#7871;t qu&#7843;
thì r&#7841;ch t&#297;nh m&#7841;ch &#273;&#7875; l&#7845;y máu ra có th&#7875;
k&#7871;t qu&#7843; t&#7889;t.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Li&#7873;u l&#432;&#7907;ng và
cách dùng<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tác d&#7909;ng &#273;i&#7873;u tr&#7883; c&#7911;a erythropoietin ph&#7909;
thu&#7897;c vào li&#7873;u; tuy nhiên li&#7873;u cao h&#417;n 300 &#273;&#417;n
v&#7883;/kg, tu&#7847;n ba l&#7847;n không cho k&#7871;t qu&#7843; t&#7889;t
h&#417;n. Li&#7873;u erythropoietin t&#7889;i &#273;a an toàn ch&#432;a
&#273;&#432;&#7907;c xác &#273;&#7883;nh. Dùng thêm s&#7855;t ho&#7863;c L -
carnitin làm t&#259;ng &#273;áp &#7913;ng v&#7899;i erythropoietin, do &#273;ó
có th&#7875; gi&#7843;m li&#7873;u thu&#7889;c c&#7847;n dùng &#273;&#7875;
kích thích t&#7841;o h&#7891;ng c&#7847;u.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Thi&#7871;u máu &#7903; ng&#432;&#7901;i b&#7879;nh suy th&#7853;n m&#7841;n
tính:</span></i><span style='font-size:9.0pt;mso-bidi-font-size:14.0pt;
line-height:150%;font-family:Verdana'> Ði&#7873;u tr&#7883; thi&#7871;u máu b&#7857;ng
erythropoietin c&#7843;i thi&#7879;n &#273;áng k&#7875; ch&#7845;t l&#432;&#7907;ng
cu&#7897;c s&#7889;ng c&#7911;a ng&#432;&#7901;i b&#7879;nh nh&#432;ng r&#7845;t
t&#7889;n kém.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tiêm t&#297;nh m&#7841;ch: Li&#7873;u ban &#273;&#7847;u th&#432;&#7901;ng
dùng là 50 - 100 &#273;&#417;n v&#7883;/kg, tu&#7847;n ba l&#7847;n. C&#7847;n
gi&#7843;m li&#7873;u erythropoietin khi hematocrit &#273;&#7841;t m&#7913;c
30% t&#7899;i 36% hay khi c&#7913; m&#7895;i hai tu&#7847;n thì hematocrit
t&#259;ng lên &#273;&#432;&#7907;c trên 4%. N&#7871;u sau 8 tu&#7847;n &#273;i&#7873;u
tr&#7883; mà hematocrit không t&#259;ng lên &#273;&#432;&#7907;c 5 &#273;&#7871;n
6% và v&#7851;n th&#7845;p h&#417;n m&#7913;c c&#7847;n &#273;&#7841;t thì c&#7847;n
ph&#7843;i t&#259;ng li&#7873;u. Hematocrit không &#273;&#432;&#7907;c
t&#259;ng cao h&#417;n 36%. C&#7847;n tính toán li&#7873;u theo t&#7915;ng
ng&#432;&#7901;i b&#7879;nh; li&#7873;u duy trì là t&#7915; 12,5 &#273;&#7871;n
525 &#273;&#417;n v&#7883;/kg, tu&#7847;n ba l&#7847;n. Hematocrit t&#259;ng ph&#7909;
thu&#7897;c vào li&#7873;u, nh&#432;ng n&#7871;u dùng li&#7873;u cao h&#417;n
300 &#273;&#417;n v&#7883;/kg, tu&#7847;n ba l&#7847;n, c&#361;ng không cho k&#7871;t
qu&#7843; t&#7889;t h&#417;n. Li&#7873;u dùng &#273;&#7875; &#273;i&#7873;u tr&#7883;
thi&#7871;u máu &#7903; ng&#432;&#7901;i b&#7879;nh m&#7855;c b&#7879;nh th&#7853;n
&#7903; giai &#273;o&#7841;n cu&#7889;i là t&#7915; 3 &#273;&#417;n v&#7883;/kg/li&#7873;u
&#273;&#7871;n 500 &#273;&#417;n v&#7883;/kg/li&#7873;u, tu&#7847;n ba l&#7847;n;
b&#7855;t &#273;&#7847;u v&#7899;i li&#7873;u th&#7845;p r&#7891;i t&#259;ng d&#7847;n
t&#7915;ng n&#7845;c tùy theo &#273;áp &#7913;ng huy&#7871;t h&#7885;c. Li&#7873;u
có th&#7875; t&#259;ng g&#7845;p hai l&#7847;n li&#7873;u tr&#432;&#7899;c và
cách nhau t&#7915; 1 &#273;&#7871;n 2 tu&#7847;n.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tiêm d&#432;&#7899;i da: Erythropoietin th&#432;&#7901;ng &#273;&#432;&#7907;c
dùng v&#7899;i li&#7873;u ban &#273;&#7847;u t&#7915; 50 - 100 &#273;&#417;n v&#7883;/kg,
tu&#7847;n ba l&#7847;n. C&#7847;n gi&#7843;m li&#7873;u erythropoietin khi
hematocrit &#273;&#7841;t m&#7913;c 30% t&#7899;i 36% hay t&#259;ng trên 4%
trong vòng 2 tu&#7847;n. C&#7847;n ph&#7843;i t&#259;ng li&#7873;u n&#7871;u
sau 8 tu&#7847;n &#273;i&#7873;u tr&#7883; mà hematocrit không t&#259;ng
&#273;&#432;&#7907;c 5 &#273;&#7871;n 6% và v&#7851;n th&#7845;p h&#417;n m&#7913;c
c&#7847;n &#273;&#7841;t. Hematocrit t&#259;ng ph&#7909; thu&#7897;c vào li&#7873;u
nh&#432;ng dùng li&#7873;u cao h&#417;n 300 &#273;&#417;n v&#7883;/kg, tu&#7847;n
ba l&#7847;n c&#361;ng không cho k&#7871;t qu&#7843; t&#7889;t h&#417;n. C&#7847;n
tính li&#7873;u theo t&#7915;ng tr&#432;&#7901;ng h&#7907;p; m&#7895;i tháng
không nên thay &#273;&#7893;i li&#7873;u quá 1 l&#7847;n, tr&#7915; khi có ch&#7881;
&#273;&#7883;nh lâm sàng. Có th&#7875; gi&#7843;m li&#7873;u duy trì m&#7895;i
tu&#7847;n xu&#7889;ng t&#7915; 23% &#273;&#7871;n 52% khi tiêm d&#432;&#7899;i
da h&#417;n là t&#297;nh m&#7841;ch (vì thu&#7889;c &#273;&#432;&#7907;c h&#7845;p
thu t&#7915; &#273;&#432;&#7901;ng d&#432;&#7899;i da ch&#7853;m h&#417;n). Li&#7873;u
tiêm d&#432;&#7899;i da &#273;&#7875; duy trì n&#7891;ng &#273;&#7897; hemoglobin
&#7903; m&#7913;c 9,4 &#273;&#7871;n 10 g/decilít là t&#7915; 2800 &#273;&#7871;n
6720 &#273;&#417;n v&#7883; m&#7895;i tu&#7847;n; so v&#7899;i 8350 &#273;&#7871;n
20300 &#273;&#417;n v&#7883; m&#7895;i tu&#7847;n khi tiêm t&#297;nh m&#7841;ch.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Erythropoietin có th&#7875; tiêm d&#432;&#7899;i da ho&#7863;c tiêm t&#297;nh
m&#7841;ch; nên dùng &#273;&#432;&#7901;ng t&#297;nh m&#7841;ch &#7903;
ng&#432;&#7901;i b&#7879;nh ph&#7843;i th&#7849;m phân. Tiêm d&#432;&#7899;i da
ph&#7843;i m&#7845;t nhi&#7873;u ngày h&#417;n &#273;&#7875; &#273;&#7841;t t&#7899;i
n&#7891;ng &#273;&#7897; hemoglobin c&#7847;n &#273;&#7841;t so v&#7899;i tiêm
t&#297;nh m&#7841;ch.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>C&#361;ng có th&#7875; tiêm erythropoietin vào b&#7855;p th&#7883;t
(c&#417; delta) v&#7899;i li&#7873;u t&#7915; 4000 &#273;&#7871;n 8000
&#273;&#417;n v&#7883;, tu&#7847;n m&#7897;t l&#7847;n; hematocrit có th&#7875;
t&#259;ng lên 30% &#273;&#7871;n 33%. Tiêm b&#7855;p ít &#273;au h&#417;n tiêm
d&#432;&#7899;i da.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Li&#7873;u khuyên dùng &#7903; tr&#7867;: Li&#7873;u dùng ban &#273;&#7847;u
là 150 &#273;&#417;n v&#7883;/kg tiêm d&#432;&#7899;i da, tu&#7847;n 3 l&#7847;n;
n&#7871;u hematocrit t&#259;ng lên &#273;&#7871;n m&#7913;c 35%, gi&#7843;m li&#7873;u
t&#7915;ng n&#7845;c 25 &#273;&#417;n v&#7883;/kg/li&#7873;u và ng&#7915;ng
dùng thu&#7889;c n&#7871;u hematocrit &#273;&#7841;t t&#7899;i m&#7913;c 40%.
Cách dùng này an toàn và hi&#7879;u qu&#7843; &#273;&#7889;i v&#7899;i tr&#7867;
em suy th&#7853;n giai &#273;o&#7841;n cu&#7889;i th&#7849;m phân màng b&#7909;ng.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ði&#7873;u ch&#7881;nh li&#7873;u trong khi th&#7849;m phân<o:p></o:p></span></i></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>L&#7885;c máu: Erythropoietin &#273;&#432;&#7907;c dùng 12 gi&#7901;
sau khi ch&#7841;y th&#7853;n nhân t&#7841;o xong.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Th&#7849;m phân phúc m&#7841;c: Cách dùng h&#7919;u hi&#7879;u là dùng
thu&#7889;c m&#7897;t, hai ho&#7863;c ba l&#7847;n m&#7897;t tu&#7847;n. Sau
khi dùng 2000 &#273;&#7871;n 8000 &#273;&#417;n v&#7883;, m&#7895;i tu&#7847;n
m&#7897;t l&#7847;n trong th&#7901;i gian t&#7915; 2 &#273;&#7871;n 10 tháng,
trung bình hematocrit t&#259;ng lên t&#7915; 20% &#273;&#7871;n 30%. Ho&#7863;c
có th&#7875; dùng li&#7873;u t&#7915; 60 &#273;&#7871;n 120 &#273;&#417;n v&#7883;/kg,
tiêm d&#432;&#7899;i da m&#7897;t tu&#7847;n hai l&#7847;n. Li&#7873;u ti&#7871;p
sau &#273;ó ph&#7843;i d&#7921;a theo &#273;áp &#7913;ng hemoglobin. Li&#7873;u
c&#7847;n dùng &#273;&#7875; duy trì n&#7891;ng &#273;&#7897; hemoglobin &#7903;
m&#7913;c t&#7915; 11 &#273;&#7871;n 11,5 g/decilít là t&#7915; 12,5 &#273;&#7871;n
50 &#273;&#417;n v&#7883;/kg, 3 l&#7847;n/tu&#7847;n.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt'>Kh&#7843; d&#7909;ng sinh h&#7885;c c&#7911;a
erythropoietin dùng theo &#273;&#432;&#7901;ng tiêm d&#432;&#7899;i da (22%) g&#7845;p
7 l&#7847;n &#273;&#432;&#7901;ng tiêm vào phúc m&#7841;c (3%); 3 &#273;&#7871;n
4 ngày sau khi tiêm d&#432;&#7899;i da, thu&#7889;c v&#7851;n còn trong huy&#7871;t
thanh.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt'>Thi&#7871;u máu &#7903; ng&#432;&#7901;i b&#7879;nh
&#273;i&#7873;u tr&#7883; b&#7857;ng zidovudin<o:p></o:p></span></i></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Li&#7873;u ban &#273;&#7847;u &#273;&#432;&#7907;c khuyên dùng &#273;&#7875;
&#273;i&#7873;u tr&#7883; thi&#7871;u máu cho ng&#432;&#7901;i b&#7879;nh nhi&#7877;m
HIV &#273;i&#7873;u tr&#7883; b&#7857;ng zidovudin là 100 &#273;&#417;n v&#7883;/kg
tiêm t&#297;nh m&#7841;ch ho&#7863;c d&#432;&#7899;i da, 3 l&#7847;n/tu&#7847;n
trong 8 tu&#7847;n. N&#7871;u sau 8 tu&#7847;n mà k&#7871;t qu&#7843; ch&#432;a
t&#7889;t thì có th&#7875; t&#259;ng thêm t&#7915; 50 &#273;&#7871;n 100
&#273;&#417;n v&#7883; cho m&#7895;i kg, <br>
3 l&#7847;n/ngày.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Thi&#7871;u máu do hóa tr&#7883; li&#7879;u ung th&#432;<o:p></o:p></span></i></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>C&#7847;n ph&#7843;i b&#7855;t &#273;&#7847;u v&#7899;i li&#7873;u 150
&#273;&#417;n v&#7883;/kg tiêm d&#432;&#7899;i da, ba l&#7847;n/tu&#7847;n. N&#7871;u
sau 8 tu&#7847;n mà k&#7871;t qu&#7843; ch&#432;a t&#7889;t thì có th&#7875;
t&#259;ng li&#7873;u lên t&#7899;i m&#7913;c 300 &#273;&#417;n v&#7883;/kg.
Dùng li&#7873;u cao h&#417;n c&#361;ng không t&#259;ng hi&#7879;u qu&#7843;.
Trong quá trình &#273;i&#7873;u tr&#7883;, n&#7871;u hematocrit cao h&#417;n
40% thì ph&#7843;i t&#7841;m ng&#7915;ng dùng erythropoietin cho &#273;&#7871;n
khi hematocrit gi&#7843;m xu&#7889;ng th&#7845;p h&#417;n 36%, sau &#273;ó c&#7847;n
gi&#7843;m 25% li&#7873;u và &#273;i&#7873;u ch&#7881;nh l&#7841;i.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ng&#432;&#7901;i b&#7879;nh ph&#7851;u thu&#7853;t<o:p></o:p></span></i></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Erythropoietin &#273;&#432;&#7907;c ch&#7881; &#273;&#7883;nh &#273;&#7875;
&#273;i&#7873;u tr&#7883; ng&#432;&#7901;i b&#7879;nh thi&#7871;u máu
(hemoglobin t&#7915; 10 &#273;&#7871;n 13 g/decilít) chu&#7849;n b&#7883; ph&#7851;u
thu&#7853;t ch&#7885;n l&#7885;c (không ph&#7843;i tim ho&#7863;c m&#7841;ch
máu) nh&#7857;m gi&#7843;m nhu c&#7847;u ph&#7843;i truy&#7873;n máu d&#7883;
gen; ho&#7863;c ng&#432;&#7901;i b&#7879;nh có nguy c&#417; cao m&#7845;t máu
nhi&#7873;u c&#7847;n ph&#7843;i &#273;&#432;&#7907;c truy&#7873;n máu tr&#432;&#7899;c,
trong, và sau ph&#7851;u thu&#7853;t. Li&#7873;u khuyên dùng là 300
&#273;&#417;n v&#7883;/kg/ngày, tiêm d&#432;&#7899;i da 10 ngày tr&#432;&#7899;c
khi m&#7893;, vào hôm m&#7893; và 4 ngày sau ph&#7851;u thu&#7853;t. M&#7897;t
cách khác là tiêm d&#432;&#7899;i da 600 &#273;&#417;n v&#7883;/kg, tu&#7847;n
m&#7897;t l&#7847;n (tr&#432;&#7899;c ngày m&#7893; 21, 14, và 7 ngày) thêm li&#7873;u
th&#7913; t&#432; vào hôm m&#7893;. C&#7847;n ph&#7843;i b&#7893; sung s&#7855;t.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Erythropoietin tiêm d&#432;&#7899;i da ho&#7863;c t&#297;nh m&#7841;ch
(300 &#273;&#417;n v&#7883;/kg/ngày cho &#273;&#7871;n khi có &#273;áp &#7913;ng
thích h&#7907;p, <span style='letter-spacing:-.1pt'>sau &#273;ó 150
&#273;&#417;n v&#7883;/kg, cách m&#7897;t ngày) trong 3 &#273;&#7871;n 10 ngày,
k&#7871;t h&#7907;p v&#7899;i folat, cyanocobalamin, u&#7889;ng ho&#7863;c tiêm
s&#7855;t và t&#259;ng</span> c&#432;&#7901;ng dinh d&#432;&#7905;ng có th&#7875;
làm hemoglobin hay hematocrit t&#259;ng m&#7895;i ngày lên 5% ho&#7863;c
h&#417;n n&#7919;a.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>V&#7899;i nh&#7919;ng ng&#432;&#7901;i b&#7879;nh b&#7883; thi&#7871;u
máu r&#7845;t n&#7863;ng, nguy hi&#7875;m &#273;&#7871;n tính m&#7841;ng mà
không mu&#7889;n ho&#7863;c không th&#7875; truy&#7873;n máu &#273;&#432;&#7907;c
thì v&#7851;n có th&#7875; cho dùng erythropoietin, m&#7863;c dù &#273;i&#7873;u
này ch&#7881; có ý ngh&#297;a nhân &#273;&#7841;o vì không có gì &#273;&#7843;m
b&#7843;o tr&#432;&#7899;c là ng&#432;&#7901;i b&#7879;nh có th&#7875; h&#7891;i
ph&#7909;c.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>T&#432;&#417;ng tác thu&#7889;c<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Dùng các thu&#7889;c &#7913;c ch&#7871; men chuy&#7875;n &#273;&#7891;ng
th&#7901;i v&#7899;i erythropoietin có th&#7875; làm t&#259;ng nguy c&#417; b&#7883;
t&#259;ng kali huy&#7871;t, &#273;&#7863;c bi&#7879;t &#7903; ng&#432;&#7901;i
b&#7879;nh gi&#7843;m ch&#7913;c n&#259;ng th&#7853;n.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Ð&#7897; &#7893;n &#273;&#7883;nh
và b&#7843;o qu&#7843;n<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ph&#7843;i b&#7843;o qu&#7843;n dung d&#7883;ch erythropoietin &#7903;
nhi&#7879;t &#273;&#7897; t&#7915; 2 &#273;&#7871;n 8<sup>o</sup>C. Không
&#273;&#432;&#7907;c &#273;&#7875; &#273;ông l&#7841;nh ho&#7863;c l&#7855;c. N&#7871;u
dùng không h&#7871;t li&#7873;u thì ph&#7843;i v&#7913;t b&#7887; thu&#7889;c
còn l&#7841;i n&#7871;u l&#7885; ch&#7871; ph&#7849;m erythropoietin &#273;ó
không ch&#7913;a ch&#7845;t b&#7843;o qu&#7843;n; các l&#7885; thu&#7889;c có
th&#7875; chia làm nhi&#7873;u li&#7873;u dùng thì có ch&#7913;a ch&#7845;t b&#7843;o
qu&#7843;n và thu&#7889;c còn l&#7841;i trong l&#7885; có th&#7875;
&#273;&#432;&#7907;c dùng ti&#7871;p.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>T&#432;&#417;ng k&#7925;<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ch&#7871; ph&#7849;m erythropoietin &#273;&#432;&#7907;c &#273;&#7879;m
b&#7857;ng dung d&#7883;ch natri clorid/ natri citrat &#273;&#7859;ng
tr&#432;&#417;ng có pH là 6,9 0,3.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Không tr&#7897;n erythropoietin v&#7899;i các thu&#7889;c khác.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Không cho thêm erythropoietin vào các dung d&#7883;ch truy&#7873;n t&#297;nh
m&#7841;ch.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Quá li&#7873;u và x&#7917; trí<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Gi&#7899;i h&#7841;n &#273;i&#7873;u tr&#7883; c&#7911;a
erythropoietin r&#7845;t r&#7897;ng. Quá li&#7873;u erythropoietin có th&#7875;
gây t&#259;ng tác d&#7909;ng d&#432;&#7907;c lý c&#7911;a hormon. Có th&#7875;
trích máu t&#297;nh m&#7841;ch n&#7871;u n&#7891;ng &#273;&#7897; hemoglobin
quá cao. N&#7871;u c&#7847;n, &#273;i&#7873;u tr&#7883; h&#7895; tr&#7907;
thêm.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Thông tin qui ch&#7871;<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Erythropoietin có trong danh m&#7909;c thu&#7889;c thi&#7871;t y&#7871;u
Vi&#7879;t Nam ban hành l&#7847;n th&#7913; t&#432; n&#259;m 1999. <o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Thu&#7889;c &#273;&#7897;c b&#7843;ng B.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

</div>

</body>


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Erythropoietin.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:06:52 GMT -->
</html>
